Psychotherapy vs antidepressants in heart failure: Impact of adherence

By afschroeder • September 6, 2026

IsHak WW, Hamilton MA, Diniz MA, Mirocha J, Chernoff R, Hedrick R, Aronow H, Darwish T, Messineo G, Pasini M, Olanisa L, Tetrault E, Arun A, Tessema KK, Harold JG, Ong MK, Spiegel B, Wells K, Danovitch I. Psychotherapy vs antidepressants in heart failure: Impact of adherence. J Affect Disord. 2026 Dec 1;414:122318. doi: 10.1016/j.jad.2026.122318. Epub 2026 Jul 30. PMID: 42532282.

Tags: Antidepressant therapy, Behavioral activation, Cedars Sinai DoM, depression, Digestive Diseases, heart failure, Publications, Randomized Controlled Trial, Treatment adherence

Related Posts

Association of Eicosanoids and Eicosanoid-Related Metabolites With Obesity and Cardiometabolic Traits

Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial

Baden LR, Shah NS, Liu STH, Cohen J, Moy J, Kumar A, McComsey GA, Chen P, Floris-Moore M, Singer NG, Fernandez I, Slandzicki AJ, Wiley[...]

L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S,[...]